{
    "Trade/Device Name(s)": [
        "BD ProbeTec\u2122 Neisseria gonorrhoeae (GC) Qx Amplified DNA Assay"
    ],
    "Submitter Information": "BD Diagnostic Systems",
    "510(k) Number": "K091730",
    "Predicate Device Reference 510(k) Number(s)": [
        "K081825",
        "K062440"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LSL"
    ],
    "Summary Letter Date": "November 13, 2009",
    "Summary Letter Received Date": "November 6, 2009",
    "Submission Date": "November 5, 2009",
    "Regulation Number(s)": [
        "21 CFR 866.3390"
    ],
    "Regulation Name(s)": [
        "Neisseria spp. direct serological test reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Neisseria gonorrhoeae DNA"
    ],
    "Specimen Type(s)": [
        "Clinician-collected female endocervical swab",
        "Male urethral swab",
        "Patient-collected vaginal swab",
        "Male urine",
        "Female urine",
        "Gynecological specimens in BD SurePath\u2122 Preservative Fluid"
    ],
    "Specimen Container(s)": [
        "Extraction Tube",
        "BD SurePath\u2122 Preservative Fluid vial",
        "LBC Specimen Dilution Tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BD Viper\u2122 System"
    ],
    "Method(s)/Technology(ies)": [
        "Strand Displacement Amplification (SDA)",
        "Fluorescence detection",
        "Automated nucleic acid extraction"
    ],
    "Methodologies": [
        "Nucleic acid amplification",
        "Qualitative DNA detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for BD ProbeTec Neisseria gonorrhoeae (GC) Qx Amplified DNA Assay using SDA technology for qualitative detection of N. gonorrhoeae DNA in swab and urine specimens on BD Viper System",
    "Indications for Use Summary": "Direct qualitative detection of Neisseria gonorrhoeae DNA in clinician-collected endocervical and male urethral swabs, patient-collected vaginal swabs, male and female urine specimens, and gynecological specimens in BD SurePath Preservative Fluid to aid in diagnosis of gonococcal urogenital disease in asymptomatic and symptomatic individuals",
    "fda_folder": "Microbiology"
}